DC Circ. Won't Kill FTC Bid For Boehringer Deal Docs
The D.C. Circuit on Friday refused to dismiss the Federal Trade Commission's bid to force Boehringer Ingelheim Pharmaceuticals Inc. to turn over allegedly privileged documents on patent settlements with Barr Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article